Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Recruiting now · Not applicable

Conditions studied: Liver Cancer Adult, Liver Regeneration

In brief

the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.

Key facts

Study ID

NCT06681818

Run by

Englewood Hospital and Medical Center

People needed

125

Starts

2025-11-21

Expected to finish

2039-01-01

Last updated by the study team

2025-07-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient plans to have partial liver resection for primary liver pathology or metastatic disease
• Patient is able to comprehend and willing to sign the written consent form

You may not qualify if…

• Patients < 18 years
• Patients identified as members of a vulnerable population, except women of child bearing potential with negative pregnancy test

Where it is running

• Englewood Hospital — Englewood, New Jersey, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.